Revance Therapeutics, Inc.
Total Trades
36
Buys
0
Sells
25
Largest Trade
N/A
Insiders
7
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
35
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Hollander David | CMO & Global Thera… | SELL | $15K–$50K | 4K | $4.17 | Nov 19, 2024 |
| Jordan Erica | Chief Commercial O… | SELL | $1K–$15K | 2K | $3.80 | Apr 17, 2024 |
| Moxie Dwight | SVP, GC & Secretary | SELL | $500K+ | 35K | $17.58 | Sep 7, 2023 |
| Foley Mark J | CEO | SELL | $500K+ | 26K | $22.57 | Aug 4, 2023 |
| Schilke Tobin | CFO | SELL | $15K–$50K | 2K | $25.04 | Jul 6, 2023 |
| Schilke Tobin | CFO | GRANT | $1K–$15K | 769 | $15.61 | Jul 6, 2023 |
| Foley Mark J | CEO | GRANT | $15K–$50K | 1K | $15.61 | Jul 6, 2023 |
| Foley Mark J | CEO | SELL | $500K+ | 26K | $24.94 | Jul 6, 2023 |
| Kolaja Carey OConnor | Director | SELL | $50K–$100K | 3K | $28.24 | Jun 20, 2023 |
| Kolaja Carey OConnor | Director | EXERCISE | $15K–$50K | 3K | $18.12 | Jun 20, 2023 |
| Sjuts Dustin S | President | SELL | $100K–$500K | 5K | $30.82 | Jun 14, 2023 |
| Foley Mark J | CEO | SELL | $500K+ | 31K | $30.72 | Jun 14, 2023 |
| Schilke Tobin | CFO | SELL | $50K–$100K | 3K | $30.64 | Jun 5, 2023 |
| Moxie Dwight | SVP, GC & Secretary | SELL | $500K+ | 21K | $34.55 | May 17, 2023 |
| Moxie Dwight | SVP, GC & Secretary | GRANT | N/A | 42K | — | May 17, 2023 |
| Schilke Tobin | CFO | SELL | $500K+ | 21K | $34.55 | May 17, 2023 |
| Schilke Tobin | CFO | GRANT | N/A | 42K | — | May 17, 2023 |
| Foley Mark J | CEO | GRANT | N/A | 176K | — | May 17, 2023 |
| Foley Mark J | CEO | SELL | $1M+ | 70K | $34.55 | May 17, 2023 |
| Sjuts Dustin S | President | SELL | $500K+ | 21K | $34.55 | May 17, 2023 |
| Sjuts Dustin S | President | GRANT | N/A | 52K | — | May 17, 2023 |
| Schilke Tobin | CFO | SELL | $100K–$500K | 3K | $31.70 | May 2, 2023 |
| Schilke Tobin | CFO | SELL | $100K–$500K | 3K | $32.15 | Apr 4, 2023 |
| Moxie Dwight | SVP, GC & Secretary | GRANT | N/A | 42K | — | Mar 10, 2023 |
| Moxie Dwight | SVP, GC & Secretary | SELL | $500K+ | 18K | $31.59 | Mar 10, 2023 |
| Schilke Tobin | CFO | SELL | $500K+ | 19K | $31.59 | Mar 10, 2023 |
| Schilke Tobin | CFO | GRANT | N/A | 42K | — | Mar 10, 2023 |
| Sjuts Dustin S | President | SELL | $500K+ | 22K | $31.59 | Mar 10, 2023 |
| Sjuts Dustin S | President | GRANT | N/A | 52K | — | Mar 10, 2023 |
| Foley Mark J | CEO | SELL | $1M+ | 70K | $31.59 | Mar 10, 2023 |
| Foley Mark J | CEO | GRANT | N/A | 176K | — | Mar 10, 2023 |
| Schilke Tobin | CFO | SELL | $100K–$500K | 3K | $33.50 | Mar 3, 2023 |
| Schilke Tobin | CFO | SELL | $100K–$500K | 3K | $34.60 | Feb 3, 2023 |
| Schilke Tobin | CFO | SELL | $15K–$50K | 1K | $31.00 | Jan 23, 2023 |
| Schilke Tobin | CFO | SELL | $100K–$500K | 4K | $27.16 | Jan 11, 2023 |
| Moxie Dwight | SVP, GC & Secretary | SELL | $100K–$500K | 11K | $27.07 | Sep 16, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 86K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · May 15, 2025
0.0%
0 shares
SC 13G/A · May 15, 2025
0.0%
0 shares
SC 13G/A · Mar 6, 2025
0.0%
0 shares
SC 13G/A · Feb 13, 2025
1.5%
1.6M shares
SC 13G · Feb 11, 2025
5.4%
5.7M shares
SC 13G · Feb 6, 2025
6.9%
7.2M shares
SC 13D/A · Jan 30, 2025
6.2%
6.6M shares
SC 13G · Jan 10, 2025
6.1%
6.4M shares
SC 13D/A · Jan 6, 2025
6.2%
6.6M shares
SC 13D/A · Dec 19, 2024
6.2%
6.6M shares
SC 13G/A · Oct 31, 2024
4.6%
4.8M shares
SC 13G/A · Oct 23, 2024
0.0%
0 shares
Capital World Investors 95-1411037
SC 13G/A · Oct 7, 2024
0.0%
0 shares
SC 13G · Sep 16, 2024
1.6%
1.6M shares
Capital World Investors 95-1411037
SC 13G/A · Sep 9, 2024
6.6%
6.9M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Apr 9, 2024
2.6%
2.8M shares
SC 13G/A · Feb 14, 2024
6.0%
5.2M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
5.8%
5.1M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 9, 2024
13.6%
11.9M shares
SC 13G/A · Jan 25, 2024
8.5%
7.5M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Jan 25, 2024
5.4%
4.8M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Jan 25, 2024
5.4%
4.8M shares
SC 13D/A · Oct 24, 2023
7.4%
6.6M shares
SC 13D · Sep 1, 2023
5.0%
4.4M shares
SC 13G/A · Feb 14, 2023
6.4%
5.3M shares
SC 13G · Feb 14, 2023
6.4%
5.2M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 13, 2023
11.5%
9.5M shares
SC 13G/A · Feb 9, 2023
6.7%
5.5M shares
SC 13G/A · Feb 3, 2023
8.6%
7.1M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Jan 27, 2023
6.0%
5.0M shares
Capital World Investors 95-1411037
SC 13G/A · Dec 9, 2022
10.3%
8.5M shares
SC 13G/A · Feb 14, 2022
6.1%
4.4M shares
Capital World Investors 95-1411037
SC 13G · Feb 11, 2022
5.2%
3.7M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Jan 18, 2022
9.4%
6.8M shares